"Das USZ steht jeden Tag allen Menschen offen und bietet medizinische Grundversorgung und Spitzenmedizin an zahlreichen Standorten in Zürich. Wir nutzen unseren universitären Wissensvorsprung, um verschiedenste Gesundheitsprobleme zu lösen: nah am Menschen, hochspezialisiert und auf dem neuesten Stand der Forschung. Auf dem Gebiet der rheumatischen und Skelettmuskel-Erkrankungen bieten wir zahlreiche diagnostische und therapeutische Dienstleistungen an. Unser spezialisiertes Abklärungs- und Behandlungsangebot wird auch von anderen Spitälern und Rheumatologinnen und Rheumatologen sowie von anderen Kliniken am Universitätsspital Zürich (USZ) genutzt."

During the past decade, University of Zurich, Department of Rheumatology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Zurich, Department of Rheumatology" #1 sponsor was "University of Zurich" with 2 trials, followed by "Gabriela Riemekasten" with 1 trials sponsored, "Gabriele Valentini" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Zurich, Department of Rheumatology" #1 collaborator was "Charite University, Berlin, Germany" with 5 trials as a collaborator, "European Union" with 5 trials as a collaborator, "Schoen Klinik Hamburg Eilbek" with 5 trials as a collaborator, "University College, London" with 5 trials as a collaborator and "University of Basel" with 5 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "University of Zurich, Department of Rheumatology" are "Systemic Sclerosis" (6 trials), "Rheumatoid Arthritis" (2 trials), "Arthritis" (1 trials), "Calcinosis Cutis in Connective Tissue Disease" (1 trials) and "Cardiac Arrhythmia" (1 trials). Many other conditions were trialed in "University of Zurich, Department of Rheumatology" in a lesser frequency.

Most popular intervention types in "University of Zurich, Department of Rheumatology" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Leflunomide" (1 trials), "Methotrexate" (1 trials), "Ocrelizumab" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Zurich, Department of Rheumatology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "University of Zurich, Department of Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Zurich, Department of Rheumatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Zurich, Department of Rheumatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".